Search

Background It is well-documented that using immunosuppressive drugs such as corticosteroids or cytokine blockers in treating coronavirus disease 2019 (COVID-19) increases the risk of co-infections. Here we systematically summarized the cases of COVID-19-associated parasitic infections (CAPIs) in Iran. Methods From 19 February 2020 to 10 May 2023, all studies on Iranian patients suffering from CAPIs were collected from several databases using a systematic search strategy. Results Of 540 records, 11 studies remained for data extraction. In this research, most of the studies were related to Lophomonas and Toxoplasma. Of 411 cases of CAPIs, toxoplasmosis (385 [93.7%]) had the highest rate of infection among Iranian patients, followed by blastocystosis (15 [3.6%]), fascioliasis (4 [0.97%]), leishmaniasis (3 [0.7%]), lophomoniasis (3 [0.7%]) and strongyloidiasis (1 [0.2%]). In general, Blastocystis enhanced diarrhoea in patients with COVID-19. Lophomonas, Toxoplasma and Strongyloides increased the severity of COVID-19, but Fasciola decreased its intensity. Patients with a history of cutaneous leishmaniasis showed mild symptoms of COVID-19. Also, patients with a prior history of hydatid cysts were not affected by COVID-19. Conclusions Due to the similar symptoms of some parasitic diseases and COVID-19 and immunosuppressive treatment regimens in these patients that may cause the reactivation or recurrence of parasitic infections, early diagnosis and treatment are required. [ABSTRACT FROM AUTHOR]

Here we report biliary fascioliasis in two women 27 and 54 years old from Ardabil Province, Iran who presented with nausea, anorexia, weight loss, and pain between shoulder blades. Endoscopic ultrasound showed distal common bile duct strictures (CBD) and a lesion in its proximal. Endoscopic retrograde cholangiopancreatography (ERCP) was performed and live parasites were diagnosed and successfully managed into the duodenal lumen. The clinical findings of the patient improved after the procedure. This report emphasizes that the prevalence of Fasciola in Ardabil is predictable and this infection could be simultaneously diagnosed and treated by the ERCP. [ABSTRACT FROM AUTHOR]

Background and purpose: The prevalence of leishmaniasis is reported in more than 98 countries and Iran is one of the endemic areas. There is no vaccine for this disease and few effective drugs are available to treat it. Moreover, drug resistance to the disease is increasing. During the past decade, several in vitro and in vivo studies have been performed on dihydropyrimidine derivatives as antileishmanial agents. Experimental approach: In the present project, a few 6-methyl-4-aryl-N-aryl dihydropyrimidinone/thiones (A7-A11) and N-heteroaryl-3-(para-methoxy benzyl) amino but-enamides (A1-A6) were synthesized, structurally characterized, and finally subjected to in vitro anti-leishmanial effect against Leishmania major promastigotes. Findings / Results: Results of the study showed that compound A10, 4-(3-chlorophenyl)-6-methyl-N-phenyl- 2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide, exhibited superior anti-leishmanial effect with IC50 value of 52.67 μg/mL (more active than standard drug Glucantim® with IC50 71000 ± 390 μg/mL). Conclusion and implications: It was demonstrated that some dihydropyrimidine thiones were able to inhibit Leishmania major promastigotes. Structure-activity relationship evaluations indicated that more electron-poor rings such as isoxazole afforded higher activity within A1-A6 series and in these derivatives, N-benzothiazole rings reinforced anti-leishmanial activity concerning thiazole. It was also observed that higher anti-parasite activities of A10 and A11 concerning A7-A9 might be related to the incorporation of the sulfur atom into C2 position, replacement of N-thiazole carboxamide by N-phenyl carboxamide on C5 position of dihydropyrimidine ring, and also replacement of para with meta-substituted phenyls within C4 of dihydropyrimidine ring. The results may help unveil new 4-aryl-5-carboxamide dihydropyrimidines as potential anti-leishmanial agents and their further structural modification toward more potent derivatives. [ABSTRACT FROM AUTHOR]

Summary: This is the first study aiming to determine the therapeutic effects of the Sambucus ebulus aquatic extract as an antileishmanial herbal drug and evaluate the immune responses in Leishmania major major infected BALB/c mice. The antileishmanial activity of S ebulus aquatic extract was evaluated using MTT test as well as parasite rescue and transformation assay. Footpad swelling and parasite load of infected mice were measured by several techniques. The immune responses were evaluated by measuring the levels of IFN‐γ, IL‐4, nitric oxide and arginase. The results indicated that S. ebulus can significantly decrease L. major promastigotes and amastigotes viability, but it was not toxic to macrophages. The lesion size, parasite burden and the level of ARG decreased in the treated infected mice, while the IFN‐γ‐to‐IL‐4 ratio and the level of NO increased significantly. Altogether, the S. ebulus extract is an effective compound for killing Leishmania parasite without excessive toxicity to the host cells and can cure the CL by switching the host immune responses towards Th1 response. Thus, it may be a perfect therapeutic option for CL treatment. [ABSTRACT FROM AUTHOR]

Contaminated water sources can result in outbreaks of parasitic infections such as Blastocystis sp. in communities, creating a substantial strain on healthcare systems and affecting the general health of the population. To ascertain the prevalence and subtype distribution of Blastocystis sp. in water sources globally, a systematic review and meta-analysis of published papers up to May 19, 2024 were carried out. A thorough search of multiple electronic databases (PubMed, Scopus, Google Scholar, and Web of Science) identified 24 studies/28 datasets meeting the inclusion criteria, encompassing 2,451 water samples from 15 countries worldwide. Water samples comprised wastewater (six datasets, 285 samples), tap/drinking water (10 datasets, 253 samples), surface water (eight datasets, 1013 samples), and uncategorized water (four datasets, 900 samples). Total estimates and 95% confidence intervals (CIs) were computed using a random-effects model. This review found that 18.8% (95% CI: 12.8-26.9%) of examined water samples contained Blastocystis sp. Wastewater showed the highest Blastocystis sp. infection rate at 35.5% (95% CI: 13.5-66.1%), followed by tap/drinking water at 19.1% (95% CI: 9.5-34.5%), surface water at 17.6% (95% CI: 7.2-36.8%), and uncategorized water at 9.9% (95% CI: 4.1-21.8%). Sensitivity analysis assessed weighted prevalence variations following the exclusion of individual studies. Subgroup analysis of Blastocystis sp. prevalence was performed based on publication years, countries, continents, WHO regions, sample sizes, and diagnostic methods. Water samples can be the source of infection for nine Blastocystis sp. subtypes (STs) (ST1-ST4, ST6, ST8, ST10, ST21, and ST24), with seven STs (ST1-ST4, ST6, ST8, and ST10) capable of infecting humans. It is important to take preventative and control measures, improve the cleanliness and quality of water sources, and promote public health awareness due to the presence of different parasites such as Blastocystis sp. in water sources.

Background: Human toxocariasis is contained in the list of neglected diseases. The infection occurs after ingestion of embryonated eggs in contaminated soil. The present study was carried out to estimate the extent of soil contamination with Toxocara spp. eggs in the public places., Methods: Soil samples were collected randomly from 41 public places in various parts in and around of Ardabil, Iran, between March 2013 and March 2014. Data were examined by microscopy following sodium nitrate flotation., Results: Of the 200 collected soil samples, 35 (17.5%) were positive for soil parasites. The eggs of Toxocara spp. were found in 14 (7%) soil samples., Conclusion: This investigation gives baseline knowledge regarding soil contamination with Toxocara spp. eggs in Ardabil city and provides information for local control of toxocariasis.

Objectives: Predegeneration is a standard technique to obtain mitotically activated and enriched cultures of Schwann cells (SCs). This study, for the first time, evaluated the impact of various duration of predegeneration on cell yield and enrichment of SCs from dog peripheral nerve., Materials and Methods: Dog sural nerves were subjected to 5, 10, 15 day-long in vitro predegeneration. The total cell yield and the purity of SCs were evaluated in each group on the first and seventh day after plating., Results: The maximum and minimum numbers of cells were counted in 15 day-long predegene-ration and control groups which underwent no predegeneration. The 10 day-long in vitro predegeneration group with 80±0.5% SCs enrichment had the best purity after plating day and could maintain its purity with elapsing on cultures., Conclusion: 10 day-long predegeneration results in the higher cell number and the better and prolonged purity of SCs in culture.

Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of health care-associated infections. In this study, a total of 173 nurses was screened for S aureus nasal colonization, of which 8 (4.6%) were MRSA carriers. Among the MRSA isolates, 6 were mecA positive and oxacillin resistant, and 2 were mecA-positive, oxacillin-susceptible (OS-MRSA) strains. Reports of the OS-MRSA strains are increasing worldwide. To the best of our knowledge, this study is the first report on the occurrence of OS-MRSA strains in Iran., (Copyright © 2013 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.)